Consequences and management of hyperphosphatemia in patients with renal insufficiency.
Progressive renal insufficiency leads to hyperphosphatemia, hypocalcemia, and secondary …

As renal function declines in patients with end-stage renal disease (ESRD), excess dietary
phosphorus accumulates in the bloodstream. Routine dialysis removes up to 70% of …

Control of serum phosphorus continues to be of utmost importance in renal replacement
therapy, due to the high prevalence of hyperphosphatemia in the dialysis population …

Hyperphosphataemia is prevalent among chronic renal failure and dialysis patients. It is
known to stimulate parathyroid hormone and suppress vitamin D3 production, thereby …

Hyperphosphatemia directly or indirectly contributes to the progression of chronic renal
disease and is an important factor in the development of secondary hyperparathyroidism …

Hyperphosphatemia is a characteristic complication of significant chronic kidney disease.
Elevated serum phosphorous is associated with reduced survival. Hyperphosphatemia has …

Hyperphosphatemia is a predictable consequence of chronic renal failure and is present in
most patients on dialysis. Traditionally, the risk associated with elevated serum phosphorus …

Controlling serum phosphorus levels continues to be a challenge in patients with chronic
renal disease. Hyperphosphatemia is implicated in the development and worsening of …

An introduction to phosphate binders for the treatment of hyperphosphatemia in patients with
chronic kidney disease. Chronic kidney disease has the potential to induce sequelae that …

Population-based studies have shown that most patients with advanced chronic kidney
disease (CKD) do not have optimal phosphate levels. Meta-analyses suggest that there is a …